| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2011 | US20110178103 Therapeutic agent for chronic renal failure |
| 07/21/2011 | US20110178102 Sir2 regulation |
| 07/21/2011 | US20110178101 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/21/2011 | US20110178100 Apoptosis inhibitor |
| 07/21/2011 | US20110178099 Pharmaceutical combination |
| 07/21/2011 | US20110178098 Anticancer compounds and methods of making and using same |
| 07/21/2011 | US20110178097 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178095 Tyrosine kinase inhibitors containing a zinc binding moiety |
| 07/21/2011 | US20110178094 Oral Formulation |
| 07/21/2011 | US20110178093 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 07/21/2011 | US20110178092 HIV-1 Protease Inhibitors |
| 07/21/2011 | US20110178091 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders |
| 07/21/2011 | US20110178090 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 07/21/2011 | US20110178089 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/21/2011 | US20110178088 Tetrahydro-naphthalene derivatives |
| 07/21/2011 | US20110178087 Compositions and Their Use as Anti-Tumor Agents |
| 07/21/2011 | US20110178086 Adamantyl diamide derivatives and uses of same |
| 07/21/2011 | US20110178085 Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 07/21/2011 | US20110178084 Therapeutic compounds |
| 07/21/2011 | US20110178083 Pde-10 inhibitors |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178080 Melanocortin Receptor-Specific Spiro-Piperidine Compounds |
| 07/21/2011 | US20110178079 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/21/2011 | US20110178078 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 07/21/2011 | US20110178077 Anti-infective compounds |
| 07/21/2011 | US20110178076 Medical intervention in haematological cancers |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178074 Antipathogenic benzamide compounds |
| 07/21/2011 | US20110178073 Methods of improving cognitive functions |
| 07/21/2011 | US20110178072 Stereospecificity of methylsulfinyl reduction |
| 07/21/2011 | US20110178071 Antiviral Treatments |
| 07/21/2011 | US20110178070 PI3K/mTOR INHIBITORS |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178068 Quaternary Ammonium Salt Prodrugs |
| 07/21/2011 | US20110178067 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 07/21/2011 | US20110178066 Hydroxypiperidine derivatives and uses thereof |
| 07/21/2011 | US20110178065 Novel cyp17 inhibitors |
| 07/21/2011 | US20110178064 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178062 Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 07/21/2011 | US20110178061 Heterocyclic derivatives for modulation of calcium channels |
| 07/21/2011 | US20110178060 Nitrogen-containing heterocyclic compound and use of same |
| 07/21/2011 | US20110178059 1,3-oxazolidin -2-one derivatives useful as cetp inhibitors |
| 07/21/2011 | US20110178058 Inhibitors of flaviviridae viruses |
| 07/21/2011 | US20110178057 Heterocyclic compound and use thereof |
| 07/21/2011 | US20110178056 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/21/2011 | US20110178055 Dual nk1/nk3 receptor antagonists |
| 07/21/2011 | US20110178054 Heterocyclic GPCR Agonists |
| 07/21/2011 | US20110178053 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 07/21/2011 | US20110178052 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 07/21/2011 | US20110178051 Topical skin care composition |
| 07/21/2011 | US20110178050 Use of cyclolignans for the treatment of a hyperactive immune system |
| 07/21/2011 | US20110178049 Avermectin/hydrocortisone compositions for treating afflictions of the skin. e.g., rosacea |
| 07/21/2011 | US20110178048 Stabilized formulation of triamcinolone acetonide |
| 07/21/2011 | US20110178047 Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
| 07/21/2011 | US20110178046 Methods for Treating Glioblastoma |
| 07/21/2011 | US20110178045 Method to induce fatty liver in animal |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178043 Inhibitors of the mevalonate pathway of streptococcus pneumoniae |
| 07/21/2011 | US20110178042 Hydroxamic Acid Derivatives Useful as Antibacterial Agents |
| 07/21/2011 | US20110178041 Heterocyclic biaryl derivative and pde inhibitor comprising same as active ingredient |
| 07/21/2011 | US20110178040 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 07/21/2011 | US20110178039 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
| 07/21/2011 | US20110178038 Indole Antiviral Compositions And Methods |
| 07/21/2011 | US20110178037 Hydrophobically enhanced aminoglycosides |
| 07/21/2011 | US20110178035 Method for obtaining pure monosialoganglioside gm1 for medical use |
| 07/21/2011 | US20110178034 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 07/21/2011 | US20110178033 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 07/21/2011 | US20110178032 Monoglyceride of Acetoacetate and Derivatives for the Treatment of Neurological Disorders |
| 07/21/2011 | US20110178026 Ricin-like toxins for treatment of cancer |
| 07/21/2011 | US20110178014 Prevention and treatment of cardiac arrhythmias |
| 07/21/2011 | US20110178007 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 07/21/2011 | US20110178002 High Affinity Ligands Bind to Clostridium Difficile Toxin A |
| 07/21/2011 | US20110178001 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 07/21/2011 | US20110177999 Therapeutic Combinations Useful in Treating CFTR Related Diseases |
| 07/21/2011 | US20110177996 Regulatory proteins in lung repair and treatment of lung disease |
| 07/21/2011 | US20110177951 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof |
| 07/21/2011 | US20110177612 Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders |
| 07/21/2011 | US20110177176 Gel-Based Compositions and Methods of Making Same |
| 07/21/2011 | US20110177173 Compounds as l-cystine crystallization inhibitors and uses thereof |
| 07/21/2011 | US20110177172 Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and gi inflammation inhibiting agents) compositions for anaemia or h. pylori infections |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177168 Composition |
| 07/21/2011 | US20110177167 Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation |
| 07/21/2011 | US20110177166 Galenical Formulation Comprising Aliskiren and Process for its Preparation by Melt Extrusion Granulation |
| 07/21/2011 | US20110177165 Multiparticulate tablet and method for the production thereof |
| 07/21/2011 | US20110177164 Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof |
| 07/21/2011 | US20110177161 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177159 Custom-formulated phospholipid microbubbles and methods and uses thereof |
| 07/21/2011 | US20110177158 Liposomes Capable of Effectively Binding the Beta Amyloid Peptide |
| 07/21/2011 | US20110177156 Sterol-Modified Amphiphilic Lipids |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177138 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |
| 07/21/2011 | US20110177137 Novel dosage form of paliperidone and process for preparing the same |
| 07/21/2011 | US20110177136 Method and product |
| 07/21/2011 | US20110177133 Use of opioid antagonists for treating urinary retention |